{"id":349480,"date":"2025-08-25T17:27:28","date_gmt":"2025-08-25T17:27:28","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-procept-biorobotics-corporation\/"},"modified":"2025-08-25T17:27:28","modified_gmt":"2025-08-25T17:27:28","slug":"how-to-buy-procept-biorobotics-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/","title":{"rendered":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"PROCEPT BioRobotics Corporation (PRCT) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve g\u00fc\u00e7l\u00fc 2025 b\u00fcy\u00fcme potansiyeline sahip bu cerrahi robotik yenilik\u00e7isinde yat\u0131r\u0131m f\u0131rsatlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"PROCEPT BioRobotics Corporation (PRCT) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve g\u00fc\u00e7l\u00fc 2025 b\u00fcy\u00fcme potansiyeline sahip bu cerrahi robotik yenilik\u00e7isinde yat\u0131r\u0131m f\u0131rsatlar\u0131n\u0131 ke\u015ffedin."},"intro":"Cerrahi robotik gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? PROCEPT BioRobotics Corporation (PRCT), bug\u00fcn t\u0131bbi teknolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. Devrim niteli\u011findeki Aquablation terapisi ve h\u0131zl\u0131 gelir b\u00fcy\u00fcmesi ile bu \u015firket, \u00fcrolojik bak\u0131m\u0131 d\u00f6n\u00fc\u015ft\u00fcr\u00fcrken potansiyelini anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bir de\u011fer yarat\u0131yor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Cerrahi robotik gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? PROCEPT BioRobotics Corporation (PRCT), bug\u00fcn t\u0131bbi teknolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. Devrim niteli\u011findeki Aquablation terapisi ve h\u0131zl\u0131 gelir b\u00fcy\u00fcmesi ile bu \u015firket, \u00fcrolojik bak\u0131m\u0131 d\u00f6n\u00fc\u015ft\u00fcr\u00fcrken potansiyelini anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bir de\u011fer yarat\u0131yor."},"body_html":"<h2>Mevcut Hisse Senedi Performans\u0131 ve Piyasa Konumu<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, PROCEPT BioRobotics Corporation (PRCT) NASDAQ borsas\u0131nda <strong>41,23 $<\/strong> fiyat\u0131ndan i\u015flem g\u00f6rmektedir. \u015eirket, daha geni\u015f piyasa zorluklar\u0131na ra\u011fmen kayda de\u011fer bir dayan\u0131kl\u0131l\u0131k ve b\u00fcy\u00fcme ivmesi g\u00f6stermi\u015f olup, yenilik\u00e7i sa\u011fl\u0131k teknolojisine maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ekici bir hikaye sunmaktad\u0131r.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>27 Ekim 2025<\/strong> tarihini i\u015faretleyin - PROCEPT bu tarihte 2025 3. \u00e7eyrek kazan\u00e7 sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, \u015firketin kazan\u00e7 duyurular\u0131 \u00f6nemli fiyat hareketlerine yol a\u00e7m\u0131\u015f, bu da hem f\u0131rsatlar hem de riskler sunmaktad\u0131r.<\/p> <p>Son kazan\u00e7 desenlerine bak\u0131ld\u0131\u011f\u0131nda, 6 A\u011fustos 2025 tarihli 2. \u00e7eyrek raporu de\u011ferli bilgiler sunmaktad\u0131r. \u015eirket, hisse ba\u015f\u0131na zarar (EPS) olarak -0,35 $ bildirmi\u015f, piyasa beklentilerini 0,06 $ a\u015farken, gelirler y\u0131ll\u0131k %48,3 art\u0131\u015fla 79,18 milyon $'a ula\u015fm\u0131\u015f ve analist beklentisi olan 75,67 milyon $'\u0131 a\u015fm\u0131\u015ft\u0131r (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PRCT\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>). Bu olumlu s\u00fcrpriz, piyasa taraf\u0131ndan hemen tepki g\u00f6rm\u00fc\u015f ve hissenin son performans\u0131n\u0131n tonunu belirlemi\u015ftir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>PROCEPT hissesi son alt\u0131 ayda \u00f6nemli dalgalanmalar ya\u015fam\u0131\u015f, bu durum hem \u015firketin b\u00fcy\u00fcme yolculu\u011funu hem de y\u00fckselen t\u0131bbi teknoloji \u015firketlerine y\u00f6nelik piyasa duyarl\u0131l\u0131\u011f\u0131n\u0131 yans\u0131tmaktad\u0131r:<\/p> <ul> <li><strong>\u015eubat-Mart 2025:<\/strong> Hisse, yat\u0131r\u0131mc\u0131lar\u0131n 2024 4. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 sindirip 2025 rehberli\u011fine odaklanmas\u0131yla 50-55 $ aral\u0131\u011f\u0131nda bir temel olu\u015fturdu.<\/li> <li><strong>Nisan-May\u0131s 2025:<\/strong> \u015eirketin tutarl\u0131 sistem yerle\u015ftirmeleri ve tekrarlayan gelir b\u00fcy\u00fcmesi g\u00f6stermesiyle momentum artarak fiyatlar 60-65 $ aral\u0131\u011f\u0131na y\u00fckseldi.<\/li> <li><strong>Haziran-Temmuz 2025:<\/strong> Baz\u0131 kar realizasyonlar\u0131 ve genel piyasa dalgalanmas\u0131, yat\u0131r\u0131mc\u0131 g\u00fcvenini test ederek fiyatlar\u0131 45-50 $ aral\u0131\u011f\u0131na \u00e7ekti.<\/li> <li><strong>A\u011fustos 2025:<\/strong> 6 A\u011fustos'taki g\u00fc\u00e7l\u00fc 2. \u00e7eyrek kazan\u00e7 raporu toparlanmay\u0131 tetikledi ve hisse yakla\u015f\u0131k 39-40 $ seviyelerinden mevcut 41,23 $ seviyelerine y\u00fckseldi.<\/li> <\/ul> <p>Genel 6 ayl\u0131k trend, \u00f6l\u00e7eklendirme zorluklar\u0131yla ba\u015fa \u00e7\u0131kan ancak g\u00fc\u00e7l\u00fc temel b\u00fcy\u00fcmeyi s\u00fcrd\u00fcren bir \u015firketi g\u00f6stermektedir. Baz\u0131 dalgalanmalara ra\u011fmen, temel i\u015f metrikleri dramatik \u015fekilde iyile\u015fmeye devam etmektedir.<\/p> <h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firketin uygulama ge\u00e7mi\u015fine dayanarak, yat\u0131r\u0131mc\u0131lar\u0131n bekleyebilecekleri \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi:<\/strong> Ortalama analist projeksiyonu 67,94 $ olup, beklentilerin \u00fczerinde bir uygulama durumunda 80,60 $'a ula\u015fma potansiyeli vard\u0131r. 2025 i\u00e7in 325,5 milyon $ gelir rehberli\u011fi, y\u0131l sonuna do\u011fru g\u00fc\u00e7l\u00fc bir ivme g\u00f6stermektedir.<\/li> <li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 64,22 $ muhafazakar bir bir y\u0131ll\u0131k projeksiyonu temsil eder, ancak bir\u00e7ok analist, \u015firketin prostat kanseri tedavisi ve uluslararas\u0131 pazarlara geni\u015flemesi nedeniyle daha y\u00fcksek seviyeler i\u00e7in potansiyel g\u00f6rmektedir.<\/li> <li><strong>2028 Projeksiyonu:<\/strong> 2028 i\u00e7in spesifik hedefler a\u00e7\u0131k\u00e7a belirtilmemi\u015f olsa da, devam eden pazar penetrasyonu ve yeni \u00fcr\u00fcn benimsemesine dayanarak 90-110 $ aral\u0131\u011f\u0131nda potansiyel \u00f6ng\u00f6r\u00fclmektedir.<\/li> <li><strong>2030 Uzun Vadeli Vizyon:<\/strong> 121,92 $ en iddial\u0131 uzun vadeli hedefi temsil eder; bu, \u00fcrolojik robotikteki b\u00fcy\u00fck adreslenebilir pazar ve Aquablation terapisi alan\u0131ndaki ilk hareket avantaj\u0131n\u0131 yans\u0131tmaktad\u0131r.<\/li> <li><strong>Karar: AL<\/strong> - G\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesi, geni\u015fleyen marjlar ve \u00f6nemli pazar f\u0131rsatlar\u0131n\u0131n birle\u015fimi, PRCT'yi orta ve uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ekici k\u0131lmaktad\u0131r.<\/li> <\/ul> <h2>PRCT Yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Risk De\u011ferlendirmesi<\/h2> <p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve PROCEPT de istisna de\u011fildir. Dikkate al\u0131nmas\u0131 gereken temel risk fakt\u00f6rleri \u015funlard\u0131r:<\/p> <ul> <li><strong>Mali S\u00fcrd\u00fcr\u00fclebilirlik Riskleri:<\/strong> \u015eirket, hisse ba\u015f\u0131na -1,51 $ zarar ile faaliyetlerine devam etmektedir (<a href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nasdaq-prct\/procept-biorobotics\">Simply Wall St Analizi<\/a>). Gelir b\u00fcy\u00fcmesi etkileyici olsa da, k\u00e2rl\u0131l\u0131\u011fa giden yol belirsizdir ve s\u00fcrekli sermaye yat\u0131r\u0131m\u0131 gerektirir.<\/li> <li><strong>Piyasa Dalgalanmas\u0131:<\/strong> 0,97-1,12 aras\u0131nda beta de\u011feri ile PRCT, genel piyasadan biraz daha y\u00fcksek volatilite g\u00f6stermektedir. 52 haftal\u0131k fiyat aral\u0131\u011f\u0131 24,83 $ ile 103,81 $ aras\u0131nda \u00f6nemli fiyat dalgalanmalar\u0131n\u0131 g\u00f6stermektedir ve bu durum yat\u0131r\u0131mc\u0131 sabr\u0131n\u0131 s\u0131nayabilir.<\/li> <li><strong>Reg\u00fclasyon ve Geri \u00d6deme Zorluklar\u0131:<\/strong> Bir t\u0131bbi cihaz \u015firketi olarak PROCEPT, s\u00fcrekli reg\u00fclasyon denetimi ve prosed\u00fcrleri i\u00e7in uygun sigorta geri \u00f6deme politikalar\u0131na ba\u011f\u0131ml\u0131d\u0131r.<\/li> <li><strong>Rekabet Ortam\u0131:<\/strong> \u015eu anda Aquablation terapisi alan\u0131nda \u00f6nc\u00fc olsa da, daha b\u00fcy\u00fck t\u0131bbi teknoloji \u015firketleri rekabet\u00e7i \u00e7\u00f6z\u00fcmlerle pazara girebilir.<\/li> <li><strong>Uygulama Riski:<\/strong> H\u0131zl\u0131 b\u00fcy\u00fcme, \u00fcretim, sat\u0131\u015f, klinik destek ve uluslararas\u0131 geni\u015fleme alanlar\u0131nda kusursuz uygulama gerektirir - herhangi bir hata performans\u0131 etkileyebilir.<\/li> <\/ul> <h2>Olumlu Sinyaller ve B\u00fcy\u00fcme Kataliz\u00f6rleri<\/h2> <p>Risklere ra\u011fmen, bir\u00e7ok olumlu g\u00f6sterge g\u00fc\u00e7l\u00fc potansiyeli i\u015faret etmektedir:<\/p> <ul> <li><strong>Patlay\u0131c\u0131 Gelir B\u00fcy\u00fcmesi:<\/strong> 2025 2. \u00e7eyre\u011finde %48 y\u0131ll\u0131k b\u00fcy\u00fcme, b\u00fcy\u00fck pazar benimsemesini g\u00f6stermektedir (<a href=\"https:\/\/www.stocktitan.net\/news\/PRCT\/procept-bio-robotics-reports-second-quarter-2025-financial-results-s94veakyikgh.html\">2025 2. \u00c7eyrek Sonu\u00e7lar\u0131<\/a>). 2025 tam y\u0131l i\u00e7in 325,5 milyon $ olarak y\u00fckseltilen rehberlik bu ivmeyi teyit etmektedir.<\/li> <li><strong>B\u00fcy\u00fcyen Kurulu Sistem Taban\u0131:<\/strong> ABD'de kurulu 595 sistem, el aletleri ve sarf malzemelerinden g\u00fc\u00e7l\u00fc tekrarlayan gelir modeli yaratmaktad\u0131r.<\/li> <li><strong>Marj \u0130yile\u015ftirmesi:<\/strong> %64,19 br\u00fct marjlar son derece sa\u011fl\u0131kl\u0131d\u0131r ve iyile\u015fmeye devam etmektedir (<a href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nasdaq-prct\/procept-biorobotics\">Finansal Metrikler<\/a>).<\/li> <li><strong>Pazar Geni\u015flemesi:<\/strong> Uluslararas\u0131 gelir 2025 2. \u00e7eyrekte %69 artarak ba\u015far\u0131l\u0131 k\u00fcresel penetrasyonu g\u00f6stermektedir.<\/li> <li><strong>\u0130novasyon Hatt\u0131:<\/strong> Prostat kanseri tedavisine geni\u015fleme, mevcut BPH oda\u011f\u0131n\u0131n \u00f6tesinde \u00e7ok daha b\u00fcy\u00fck bir adreslenebilir pazar sunmaktad\u0131r.<\/li> <\/ul> <h2>\u00d6nemli Haberler ve Piyasa Etkisi Analizi<\/h2> <p>Son alt\u0131 ay PROCEPT BioRobotics i\u00e7in d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc olmu\u015ftur:<\/p> <ul> <li><strong>2025 2. \u00c7eyrek Kazan\u00e7 A\u015f\u0131m\u0131 (6 A\u011fustos 2025):<\/strong> \u015eirket, hem gelir hem de EPS beklentilerini a\u015farak an\u0131nda olumlu fiyat hareketi ve yenilenmi\u015f yat\u0131r\u0131mc\u0131 g\u00fcveni sa\u011flam\u0131\u015ft\u0131r.<\/li> <li><strong>Liderlik De\u011fi\u015fikli\u011fi Duyurusu:<\/strong> 2 Eyl\u00fcl 2025 itibar\u0131yla CEO olarak atanan Larry Wood, \u015firketin bir sonraki b\u00fcy\u00fcme a\u015famas\u0131n\u0131 y\u00f6nlendirmek i\u00e7in 40 y\u0131ll\u0131k t\u0131bbi teknoloji deneyimi getirmektedir.<\/li> <li><strong>Kategori I CPT Kodu Atamas\u0131:<\/strong> Bu reg\u00fclasyon d\u00f6n\u00fcm noktas\u0131, Aquablation terapisi i\u00e7in geri \u00f6deme beklentilerini ve eri\u015filebilirli\u011fi art\u0131rarak benimsemeyi h\u0131zland\u0131rabilir.<\/li> <li><strong>Klinik Kan\u0131t Geni\u015flemesi:<\/strong> 150'den fazla hakemli yay\u0131n art\u0131k Aquablation terapisini destekleyerek klinik g\u00fcvenilirlik olu\u015fturmakta ve hekim benimsemesini art\u0131rmaktad\u0131r.<\/li> <\/ul> <h2>Yat\u0131r\u0131m Stratejisi: Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p>Kapsaml\u0131 analizlere dayanarak, yeni yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nerilerim \u015funlard\u0131r:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n Ama Hemen Ba\u015flay\u0131n:<\/strong> Dalgalanma g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, geri \u00e7ekilmelerde ekleme yapabilece\u011finiz k\u00fc\u00e7\u00fck bir pozisyonla ba\u015flay\u0131n. Uzun vadeli b\u00fcy\u00fcme hikayesi hala \u00e7ekicidir.<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131 Yap\u0131n:<\/strong> M\u00fckemmel giri\u015f zaman\u0131n\u0131 yakalamaya \u00e7al\u0131\u015fmak yerine, dalgalanmay\u0131 yumu\u015fatmak i\u00e7in d\u00fczenli yat\u0131r\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun:<\/strong> Geni\u015f piyasa zay\u0131fl\u0131\u011f\u0131 cazip giri\u015f noktalar\u0131 yarat\u0131rsa, 35-38 $ civar\u0131ndaki \u00f6nemli seviyeleri izleyin.<\/li> <li><strong>Uzun Vadeye Odaklan\u0131n:<\/strong> Bu h\u0131zl\u0131 bir i\u015flem de\u011fildir - k\u00e2rl\u0131l\u0131k ortaya \u00e7\u0131kana kadar 2-3 y\u0131l tutmay\u0131 planlay\u0131n.<\/li> <li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc:<\/strong> \"PRCT ticareti yapmak robotik cerrahi yapmak gibidir - sab\u0131rl\u0131 ve dengeli eller en iyi sonu\u00e7lar\u0131 verir. Dalgalanma s\u0131ras\u0131nda panik sat\u0131\u015f\u0131 yapmak, bah\u00e7e hortumuyla Aquablation terapisi yapmaya \u00e7al\u0131\u015fmak gibidir!\"<\/li> <\/ol> <h2>PRCT Hisseleri Alma Ad\u0131m Ad\u0131m Rehberi<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Fonlar\u0131 g\u00fcvenli \u015fekilde transfer edin; bir\u00e7ok platform h\u0131zl\u0131 ticaret i\u00e7in an\u0131nda para yat\u0131rma sunar<\/td><\/tr> <tr><td>3<\/td><td>\"PRCT\" Aramas\u0131 Yap\u0131n<\/td><td>PROCEPT BioRobotics Corporation'\u0131 bulmak i\u00e7in tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Mevcut Fiyat\u0131 \u0130nceleyin<\/td><td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 25 A\u011fustos 2025 itibar\u0131yla 41,23 $ ve son performans\u0131 kontrol edin<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc Belirleyin<\/td><td>Risk tolerans\u0131n\u0131za g\u00f6re hesaplay\u0131n - genellikle volatil hisseler i\u00e7in portf\u00f6y\u00fcn %2-5'i<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 Ger\u00e7ekle\u015ftirin<\/td><td>Miktar, fiyat ve tahmini komisyon dahil sipari\u015f detaylar\u0131n\u0131 onaylay\u0131n<\/td><\/tr> <tr><td>8<\/td><td>\u0130zleme Uyar\u0131lar\u0131 Kurun<\/td><td>Kazan\u00e7 tarihleri ve \u00f6nemli teknik seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 olu\u015fturun<\/td><\/tr> <tr><td>9<\/td><td>Yat\u0131r\u0131m Tezini Belgeleyin<\/td><td>Dalgalanma s\u0131ras\u0131nda duygusal kararlar almamak i\u00e7in neden yat\u0131r\u0131m yapt\u0131\u011f\u0131n\u0131z\u0131 not edin<\/td><\/tr> <tr><td>10<\/td><td>\u00c7\u0131k\u0131\u015f Stratejisi Planlay\u0131n<\/td><td>Duygular kontrol\u00fc ele almadan \u00f6nce kar alma seviyeleri ve zarar durdurma parametrelerini belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option'\u0131n \u00c7ekicili\u011fi<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, PRCT gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunmaktad\u0131r:<\/p> <ul> <li><strong>Minimum Giri\u015f Engeli:<\/strong> D\u00fc\u015f\u00fck minimum depozito gereksinimi ile yeni yat\u0131r\u0131mc\u0131lar, \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan umut vadeden \u015firketlerde pozisyon olu\u015fturmaya ba\u015flayabilir.<\/li> <li><strong>H\u0131zl\u0131 Hesap Do\u011frulama:<\/strong> Tek belge ile kolayla\u015ft\u0131r\u0131lm\u0131\u015f KYC s\u00fcreci, f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda h\u0131zl\u0131ca ticarete ba\u015flaman\u0131z\u0131 sa\u011flar.<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri:<\/strong> Birden fazla fonlama ve \u00e7ekim y\u00f6ntemi, yat\u0131r\u0131m sermayesini y\u00f6netmede esneklik sunar.<\/li> <li><strong>E\u011fitim Kaynaklar\u0131:<\/strong> <a href=\"\/blog\">Pocket Option blogu<\/a>, t\u0131bbi teknoloji hisseleri gibi karma\u015f\u0131k piyasalarda gezinmeyi \u00f6\u011frenen yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011ferli bilgiler sunar.<\/li> <\/ul> <h2>\u015eirket Genel Bak\u0131\u015f\u0131 ve Piyasa Konumu<\/h2> <p>PROCEPT BioRobotics Corporation, \u00f6zellikle \u00fcrolojik uygulamalara odaklanan cerrahi robotik yenili\u011finin \u00f6nc\u00fcs\u00fcd\u00fcr. \u015eirketin amiral gemisi teknolojisi - HYDROS Robotik Sistemi kullan\u0131larak uygulanan Aquablation terapisi - yaln\u0131zca ABD'de yakla\u015f\u0131k 40 milyon erke\u011fi etkileyen benign prostat hiperplazisi (BPH) tedavisinde bir at\u0131l\u0131m niteli\u011findedir.<\/p> <p>PROCEPT'i \u00f6zellikle ilgin\u00e7 k\u0131lan, robotik Aquablation terapisinde ilk hareket avantaj\u0131na sahip olmas\u0131d\u0131r. Geleneksel cerrahi yakla\u015f\u0131mlar\u0131n aksine, teknolojileri, prostat boyutundan veya cerrah deneyiminden ba\u011f\u0131ms\u0131z olarak ultrason rehberli\u011finde, \u0131s\u0131 i\u00e7ermeyen su jeti ablasyonu kullan\u0131r. Bu standartla\u015ft\u0131rma potansiyeli, \u00fcrolojik bak\u0131m\u0131 d\u00f6n\u00fc\u015ft\u00fcr\u00fcrken \u00f6l\u00e7eklenebilir bir i\u015f modeli yaratmaktad\u0131r.<\/p> <p>\u015eirketin b\u00fcy\u00fcme stratejisi \u00fc\u00e7 temel \u00fczerine kuruludur: ABD'deki kurulu sistem taban\u0131n\u0131 geni\u015fletmek (\u015fu anda 595 sistem), uluslararas\u0131 benimsemeyi h\u0131zland\u0131rmak ve BPH'nin \u00f6tesinde prostat kanseri tedavisi gibi yeni uygulamalar geli\u015ftirmek. Bu \u00e7ok y\u00f6nl\u00fc yakla\u015f\u0131m, tek pazar ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltan birden fazla b\u00fcy\u00fcme vekt\u00f6r\u00fc sa\u011flar.<\/p> <p><strong>2025'ten \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> PROCEPT'in teknolojisi, Amerikan \u00dcroloji Derne\u011fi Y\u0131ll\u0131k Toplant\u0131s\u0131'nda \u00f6ne \u00e7\u0131kar\u0131ld\u0131; burada \u00f6nde gelen hekimler, yapay zeka destekli robotik sistemlerinin geleneksel y\u00f6ntemlere k\u0131yasla prostat prosed\u00fcrlerini yakla\u015f\u0131k yar\u0131 s\u00fcrede tamamlayabildi\u011fini ve hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirdi\u011fini g\u00f6sterdi. Bu klinik do\u011frulama, hastalar\u0131 i\u00e7in daha iyi \u00e7\u00f6z\u00fcmler arayan \u00fcrologlar aras\u0131nda h\u0131zl\u0131 benimsemeyi desteklemeye devam etmektedir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Mevcut Hisse Senedi Performans\u0131 ve Piyasa Konumu<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, PROCEPT BioRobotics Corporation (PRCT) NASDAQ borsas\u0131nda <strong>41,23 $<\/strong> fiyat\u0131ndan i\u015flem g\u00f6rmektedir. \u015eirket, daha geni\u015f piyasa zorluklar\u0131na ra\u011fmen kayda de\u011fer bir dayan\u0131kl\u0131l\u0131k ve b\u00fcy\u00fcme ivmesi g\u00f6stermi\u015f olup, yenilik\u00e7i sa\u011fl\u0131k teknolojisine maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ekici bir hikaye sunmaktad\u0131r.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>27 Ekim 2025<\/strong> tarihini i\u015faretleyin &#8211; PROCEPT bu tarihte 2025 3. \u00e7eyrek kazan\u00e7 sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, \u015firketin kazan\u00e7 duyurular\u0131 \u00f6nemli fiyat hareketlerine yol a\u00e7m\u0131\u015f, bu da hem f\u0131rsatlar hem de riskler sunmaktad\u0131r.<\/p>\n<p>Son kazan\u00e7 desenlerine bak\u0131ld\u0131\u011f\u0131nda, 6 A\u011fustos 2025 tarihli 2. \u00e7eyrek raporu de\u011ferli bilgiler sunmaktad\u0131r. \u015eirket, hisse ba\u015f\u0131na zarar (EPS) olarak -0,35 $ bildirmi\u015f, piyasa beklentilerini 0,06 $ a\u015farken, gelirler y\u0131ll\u0131k %48,3 art\u0131\u015fla 79,18 milyon $&#8217;a ula\u015fm\u0131\u015f ve analist beklentisi olan 75,67 milyon $&#8217;\u0131 a\u015fm\u0131\u015ft\u0131r (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PRCT\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>). Bu olumlu s\u00fcrpriz, piyasa taraf\u0131ndan hemen tepki g\u00f6rm\u00fc\u015f ve hissenin son performans\u0131n\u0131n tonunu belirlemi\u015ftir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>PROCEPT hissesi son alt\u0131 ayda \u00f6nemli dalgalanmalar ya\u015fam\u0131\u015f, bu durum hem \u015firketin b\u00fcy\u00fcme yolculu\u011funu hem de y\u00fckselen t\u0131bbi teknoloji \u015firketlerine y\u00f6nelik piyasa duyarl\u0131l\u0131\u011f\u0131n\u0131 yans\u0131tmaktad\u0131r:<\/p>\n<ul>\n<li><strong>\u015eubat-Mart 2025:<\/strong> Hisse, yat\u0131r\u0131mc\u0131lar\u0131n 2024 4. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 sindirip 2025 rehberli\u011fine odaklanmas\u0131yla 50-55 $ aral\u0131\u011f\u0131nda bir temel olu\u015fturdu.<\/li>\n<li><strong>Nisan-May\u0131s 2025:<\/strong> \u015eirketin tutarl\u0131 sistem yerle\u015ftirmeleri ve tekrarlayan gelir b\u00fcy\u00fcmesi g\u00f6stermesiyle momentum artarak fiyatlar 60-65 $ aral\u0131\u011f\u0131na y\u00fckseldi.<\/li>\n<li><strong>Haziran-Temmuz 2025:<\/strong> Baz\u0131 kar realizasyonlar\u0131 ve genel piyasa dalgalanmas\u0131, yat\u0131r\u0131mc\u0131 g\u00fcvenini test ederek fiyatlar\u0131 45-50 $ aral\u0131\u011f\u0131na \u00e7ekti.<\/li>\n<li><strong>A\u011fustos 2025:<\/strong> 6 A\u011fustos&#8217;taki g\u00fc\u00e7l\u00fc 2. \u00e7eyrek kazan\u00e7 raporu toparlanmay\u0131 tetikledi ve hisse yakla\u015f\u0131k 39-40 $ seviyelerinden mevcut 41,23 $ seviyelerine y\u00fckseldi.<\/li>\n<\/ul>\n<p>Genel 6 ayl\u0131k trend, \u00f6l\u00e7eklendirme zorluklar\u0131yla ba\u015fa \u00e7\u0131kan ancak g\u00fc\u00e7l\u00fc temel b\u00fcy\u00fcmeyi s\u00fcrd\u00fcren bir \u015firketi g\u00f6stermektedir. Baz\u0131 dalgalanmalara ra\u011fmen, temel i\u015f metrikleri dramatik \u015fekilde iyile\u015fmeye devam etmektedir.<\/p>\n<h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firketin uygulama ge\u00e7mi\u015fine dayanarak, yat\u0131r\u0131mc\u0131lar\u0131n bekleyebilecekleri \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi:<\/strong> Ortalama analist projeksiyonu 67,94 $ olup, beklentilerin \u00fczerinde bir uygulama durumunda 80,60 $&#8217;a ula\u015fma potansiyeli vard\u0131r. 2025 i\u00e7in 325,5 milyon $ gelir rehberli\u011fi, y\u0131l sonuna do\u011fru g\u00fc\u00e7l\u00fc bir ivme g\u00f6stermektedir.<\/li>\n<li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 64,22 $ muhafazakar bir bir y\u0131ll\u0131k projeksiyonu temsil eder, ancak bir\u00e7ok analist, \u015firketin prostat kanseri tedavisi ve uluslararas\u0131 pazarlara geni\u015flemesi nedeniyle daha y\u00fcksek seviyeler i\u00e7in potansiyel g\u00f6rmektedir.<\/li>\n<li><strong>2028 Projeksiyonu:<\/strong> 2028 i\u00e7in spesifik hedefler a\u00e7\u0131k\u00e7a belirtilmemi\u015f olsa da, devam eden pazar penetrasyonu ve yeni \u00fcr\u00fcn benimsemesine dayanarak 90-110 $ aral\u0131\u011f\u0131nda potansiyel \u00f6ng\u00f6r\u00fclmektedir.<\/li>\n<li><strong>2030 Uzun Vadeli Vizyon:<\/strong> 121,92 $ en iddial\u0131 uzun vadeli hedefi temsil eder; bu, \u00fcrolojik robotikteki b\u00fcy\u00fck adreslenebilir pazar ve Aquablation terapisi alan\u0131ndaki ilk hareket avantaj\u0131n\u0131 yans\u0131tmaktad\u0131r.<\/li>\n<li><strong>Karar: AL<\/strong> &#8211; G\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesi, geni\u015fleyen marjlar ve \u00f6nemli pazar f\u0131rsatlar\u0131n\u0131n birle\u015fimi, PRCT&#8217;yi orta ve uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ekici k\u0131lmaktad\u0131r.<\/li>\n<\/ul>\n<h2>PRCT Yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Risk De\u011ferlendirmesi<\/h2>\n<p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve PROCEPT de istisna de\u011fildir. Dikkate al\u0131nmas\u0131 gereken temel risk fakt\u00f6rleri \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>Mali S\u00fcrd\u00fcr\u00fclebilirlik Riskleri:<\/strong> \u015eirket, hisse ba\u015f\u0131na -1,51 $ zarar ile faaliyetlerine devam etmektedir (<a href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nasdaq-prct\/procept-biorobotics\">Simply Wall St Analizi<\/a>). Gelir b\u00fcy\u00fcmesi etkileyici olsa da, k\u00e2rl\u0131l\u0131\u011fa giden yol belirsizdir ve s\u00fcrekli sermaye yat\u0131r\u0131m\u0131 gerektirir.<\/li>\n<li><strong>Piyasa Dalgalanmas\u0131:<\/strong> 0,97-1,12 aras\u0131nda beta de\u011feri ile PRCT, genel piyasadan biraz daha y\u00fcksek volatilite g\u00f6stermektedir. 52 haftal\u0131k fiyat aral\u0131\u011f\u0131 24,83 $ ile 103,81 $ aras\u0131nda \u00f6nemli fiyat dalgalanmalar\u0131n\u0131 g\u00f6stermektedir ve bu durum yat\u0131r\u0131mc\u0131 sabr\u0131n\u0131 s\u0131nayabilir.<\/li>\n<li><strong>Reg\u00fclasyon ve Geri \u00d6deme Zorluklar\u0131:<\/strong> Bir t\u0131bbi cihaz \u015firketi olarak PROCEPT, s\u00fcrekli reg\u00fclasyon denetimi ve prosed\u00fcrleri i\u00e7in uygun sigorta geri \u00f6deme politikalar\u0131na ba\u011f\u0131ml\u0131d\u0131r.<\/li>\n<li><strong>Rekabet Ortam\u0131:<\/strong> \u015eu anda Aquablation terapisi alan\u0131nda \u00f6nc\u00fc olsa da, daha b\u00fcy\u00fck t\u0131bbi teknoloji \u015firketleri rekabet\u00e7i \u00e7\u00f6z\u00fcmlerle pazara girebilir.<\/li>\n<li><strong>Uygulama Riski:<\/strong> H\u0131zl\u0131 b\u00fcy\u00fcme, \u00fcretim, sat\u0131\u015f, klinik destek ve uluslararas\u0131 geni\u015fleme alanlar\u0131nda kusursuz uygulama gerektirir &#8211; herhangi bir hata performans\u0131 etkileyebilir.<\/li>\n<\/ul>\n<h2>Olumlu Sinyaller ve B\u00fcy\u00fcme Kataliz\u00f6rleri<\/h2>\n<p>Risklere ra\u011fmen, bir\u00e7ok olumlu g\u00f6sterge g\u00fc\u00e7l\u00fc potansiyeli i\u015faret etmektedir:<\/p>\n<ul>\n<li><strong>Patlay\u0131c\u0131 Gelir B\u00fcy\u00fcmesi:<\/strong> 2025 2. \u00e7eyre\u011finde %48 y\u0131ll\u0131k b\u00fcy\u00fcme, b\u00fcy\u00fck pazar benimsemesini g\u00f6stermektedir (<a href=\"https:\/\/www.stocktitan.net\/news\/PRCT\/procept-bio-robotics-reports-second-quarter-2025-financial-results-s94veakyikgh.html\">2025 2. \u00c7eyrek Sonu\u00e7lar\u0131<\/a>). 2025 tam y\u0131l i\u00e7in 325,5 milyon $ olarak y\u00fckseltilen rehberlik bu ivmeyi teyit etmektedir.<\/li>\n<li><strong>B\u00fcy\u00fcyen Kurulu Sistem Taban\u0131:<\/strong> ABD&#8217;de kurulu 595 sistem, el aletleri ve sarf malzemelerinden g\u00fc\u00e7l\u00fc tekrarlayan gelir modeli yaratmaktad\u0131r.<\/li>\n<li><strong>Marj \u0130yile\u015ftirmesi:<\/strong> %64,19 br\u00fct marjlar son derece sa\u011fl\u0131kl\u0131d\u0131r ve iyile\u015fmeye devam etmektedir (<a href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nasdaq-prct\/procept-biorobotics\">Finansal Metrikler<\/a>).<\/li>\n<li><strong>Pazar Geni\u015flemesi:<\/strong> Uluslararas\u0131 gelir 2025 2. \u00e7eyrekte %69 artarak ba\u015far\u0131l\u0131 k\u00fcresel penetrasyonu g\u00f6stermektedir.<\/li>\n<li><strong>\u0130novasyon Hatt\u0131:<\/strong> Prostat kanseri tedavisine geni\u015fleme, mevcut BPH oda\u011f\u0131n\u0131n \u00f6tesinde \u00e7ok daha b\u00fcy\u00fck bir adreslenebilir pazar sunmaktad\u0131r.<\/li>\n<\/ul>\n<h2>\u00d6nemli Haberler ve Piyasa Etkisi Analizi<\/h2>\n<p>Son alt\u0131 ay PROCEPT BioRobotics i\u00e7in d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc olmu\u015ftur:<\/p>\n<ul>\n<li><strong>2025 2. \u00c7eyrek Kazan\u00e7 A\u015f\u0131m\u0131 (6 A\u011fustos 2025):<\/strong> \u015eirket, hem gelir hem de EPS beklentilerini a\u015farak an\u0131nda olumlu fiyat hareketi ve yenilenmi\u015f yat\u0131r\u0131mc\u0131 g\u00fcveni sa\u011flam\u0131\u015ft\u0131r.<\/li>\n<li><strong>Liderlik De\u011fi\u015fikli\u011fi Duyurusu:<\/strong> 2 Eyl\u00fcl 2025 itibar\u0131yla CEO olarak atanan Larry Wood, \u015firketin bir sonraki b\u00fcy\u00fcme a\u015famas\u0131n\u0131 y\u00f6nlendirmek i\u00e7in 40 y\u0131ll\u0131k t\u0131bbi teknoloji deneyimi getirmektedir.<\/li>\n<li><strong>Kategori I CPT Kodu Atamas\u0131:<\/strong> Bu reg\u00fclasyon d\u00f6n\u00fcm noktas\u0131, Aquablation terapisi i\u00e7in geri \u00f6deme beklentilerini ve eri\u015filebilirli\u011fi art\u0131rarak benimsemeyi h\u0131zland\u0131rabilir.<\/li>\n<li><strong>Klinik Kan\u0131t Geni\u015flemesi:<\/strong> 150&#8217;den fazla hakemli yay\u0131n art\u0131k Aquablation terapisini destekleyerek klinik g\u00fcvenilirlik olu\u015fturmakta ve hekim benimsemesini art\u0131rmaktad\u0131r.<\/li>\n<\/ul>\n<h2>Yat\u0131r\u0131m Stratejisi: Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p>Kapsaml\u0131 analizlere dayanarak, yeni yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nerilerim \u015funlard\u0131r:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n Ama Hemen Ba\u015flay\u0131n:<\/strong> Dalgalanma g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, geri \u00e7ekilmelerde ekleme yapabilece\u011finiz k\u00fc\u00e7\u00fck bir pozisyonla ba\u015flay\u0131n. Uzun vadeli b\u00fcy\u00fcme hikayesi hala \u00e7ekicidir.<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131 Yap\u0131n:<\/strong> M\u00fckemmel giri\u015f zaman\u0131n\u0131 yakalamaya \u00e7al\u0131\u015fmak yerine, dalgalanmay\u0131 yumu\u015fatmak i\u00e7in d\u00fczenli yat\u0131r\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun:<\/strong> Geni\u015f piyasa zay\u0131fl\u0131\u011f\u0131 cazip giri\u015f noktalar\u0131 yarat\u0131rsa, 35-38 $ civar\u0131ndaki \u00f6nemli seviyeleri izleyin.<\/li>\n<li><strong>Uzun Vadeye Odaklan\u0131n:<\/strong> Bu h\u0131zl\u0131 bir i\u015flem de\u011fildir &#8211; k\u00e2rl\u0131l\u0131k ortaya \u00e7\u0131kana kadar 2-3 y\u0131l tutmay\u0131 planlay\u0131n.<\/li>\n<li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc:<\/strong> &#8220;PRCT ticareti yapmak robotik cerrahi yapmak gibidir &#8211; sab\u0131rl\u0131 ve dengeli eller en iyi sonu\u00e7lar\u0131 verir. Dalgalanma s\u0131ras\u0131nda panik sat\u0131\u015f\u0131 yapmak, bah\u00e7e hortumuyla Aquablation terapisi yapmaya \u00e7al\u0131\u015fmak gibidir!&#8221;<\/li>\n<\/ol>\n<h2>PRCT Hisseleri Alma Ad\u0131m Ad\u0131m Rehberi<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Fonlar\u0131 g\u00fcvenli \u015fekilde transfer edin; bir\u00e7ok platform h\u0131zl\u0131 ticaret i\u00e7in an\u0131nda para yat\u0131rma sunar<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;PRCT&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>PROCEPT BioRobotics Corporation&#8217;\u0131 bulmak i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Mevcut Fiyat\u0131 \u0130nceleyin<\/td>\n<td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 25 A\u011fustos 2025 itibar\u0131yla 41,23 $ ve son performans\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc Belirleyin<\/td>\n<td>Risk tolerans\u0131n\u0131za g\u00f6re hesaplay\u0131n &#8211; genellikle volatil hisseler i\u00e7in portf\u00f6y\u00fcn %2-5&#8217;i<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 Ger\u00e7ekle\u015ftirin<\/td>\n<td>Miktar, fiyat ve tahmini komisyon dahil sipari\u015f detaylar\u0131n\u0131 onaylay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u0130zleme Uyar\u0131lar\u0131 Kurun<\/td>\n<td>Kazan\u00e7 tarihleri ve \u00f6nemli teknik seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 olu\u015fturun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Yat\u0131r\u0131m Tezini Belgeleyin<\/td>\n<td>Dalgalanma s\u0131ras\u0131nda duygusal kararlar almamak i\u00e7in neden yat\u0131r\u0131m yapt\u0131\u011f\u0131n\u0131z\u0131 not edin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejisi Planlay\u0131n<\/td>\n<td>Duygular kontrol\u00fc ele almadan \u00f6nce kar alma seviyeleri ve zarar durdurma parametrelerini belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option&#8217;\u0131n \u00c7ekicili\u011fi<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, PRCT gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunmaktad\u0131r:<\/p>\n<ul>\n<li><strong>Minimum Giri\u015f Engeli:<\/strong> D\u00fc\u015f\u00fck minimum depozito gereksinimi ile yeni yat\u0131r\u0131mc\u0131lar, \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan umut vadeden \u015firketlerde pozisyon olu\u015fturmaya ba\u015flayabilir.<\/li>\n<li><strong>H\u0131zl\u0131 Hesap Do\u011frulama:<\/strong> Tek belge ile kolayla\u015ft\u0131r\u0131lm\u0131\u015f KYC s\u00fcreci, f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda h\u0131zl\u0131ca ticarete ba\u015flaman\u0131z\u0131 sa\u011flar.<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri:<\/strong> Birden fazla fonlama ve \u00e7ekim y\u00f6ntemi, yat\u0131r\u0131m sermayesini y\u00f6netmede esneklik sunar.<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131:<\/strong> <a href=\"\/blog\">Pocket Option blogu<\/a>, t\u0131bbi teknoloji hisseleri gibi karma\u015f\u0131k piyasalarda gezinmeyi \u00f6\u011frenen yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011ferli bilgiler sunar.<\/li>\n<\/ul>\n<h2>\u015eirket Genel Bak\u0131\u015f\u0131 ve Piyasa Konumu<\/h2>\n<p>PROCEPT BioRobotics Corporation, \u00f6zellikle \u00fcrolojik uygulamalara odaklanan cerrahi robotik yenili\u011finin \u00f6nc\u00fcs\u00fcd\u00fcr. \u015eirketin amiral gemisi teknolojisi &#8211; HYDROS Robotik Sistemi kullan\u0131larak uygulanan Aquablation terapisi &#8211; yaln\u0131zca ABD&#8217;de yakla\u015f\u0131k 40 milyon erke\u011fi etkileyen benign prostat hiperplazisi (BPH) tedavisinde bir at\u0131l\u0131m niteli\u011findedir.<\/p>\n<p>PROCEPT&#8217;i \u00f6zellikle ilgin\u00e7 k\u0131lan, robotik Aquablation terapisinde ilk hareket avantaj\u0131na sahip olmas\u0131d\u0131r. Geleneksel cerrahi yakla\u015f\u0131mlar\u0131n aksine, teknolojileri, prostat boyutundan veya cerrah deneyiminden ba\u011f\u0131ms\u0131z olarak ultrason rehberli\u011finde, \u0131s\u0131 i\u00e7ermeyen su jeti ablasyonu kullan\u0131r. Bu standartla\u015ft\u0131rma potansiyeli, \u00fcrolojik bak\u0131m\u0131 d\u00f6n\u00fc\u015ft\u00fcr\u00fcrken \u00f6l\u00e7eklenebilir bir i\u015f modeli yaratmaktad\u0131r.<\/p>\n<p>\u015eirketin b\u00fcy\u00fcme stratejisi \u00fc\u00e7 temel \u00fczerine kuruludur: ABD&#8217;deki kurulu sistem taban\u0131n\u0131 geni\u015fletmek (\u015fu anda 595 sistem), uluslararas\u0131 benimsemeyi h\u0131zland\u0131rmak ve BPH&#8217;nin \u00f6tesinde prostat kanseri tedavisi gibi yeni uygulamalar geli\u015ftirmek. Bu \u00e7ok y\u00f6nl\u00fc yakla\u015f\u0131m, tek pazar ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltan birden fazla b\u00fcy\u00fcme vekt\u00f6r\u00fc sa\u011flar.<\/p>\n<p><strong>2025&#8217;ten \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> PROCEPT&#8217;in teknolojisi, Amerikan \u00dcroloji Derne\u011fi Y\u0131ll\u0131k Toplant\u0131s\u0131&#8217;nda \u00f6ne \u00e7\u0131kar\u0131ld\u0131; burada \u00f6nde gelen hekimler, yapay zeka destekli robotik sistemlerinin geleneksel y\u00f6ntemlere k\u0131yasla prostat prosed\u00fcrlerini yakla\u015f\u0131k yar\u0131 s\u00fcrede tamamlayabildi\u011fini ve hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirdi\u011fini g\u00f6sterdi. Bu klinik do\u011frulama, hastalar\u0131 i\u00e7in daha iyi \u00e7\u00f6z\u00fcmler arayan \u00fcrologlar aras\u0131nda h\u0131zl\u0131 benimsemeyi desteklemeye devam etmektedir.<\/p>\n"},"faq":[{"question":"PROCEPT BioRobotics Corporation (PRCT) hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"PRCT\" sembol\u00fc ile hisseyi aray\u0131n, mevcut fiyat\u0131 kontrol edin, uygun sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in, pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc belirleyin ve sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin."},{"question":"PROCEPT hisseleri i\u00e7in 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistlerin ortalama tahmini 67,94 $ olup, beklentilerin \u00fczerinde bir performans durumunda 80,60 $'a kadar \u00e7\u0131kabilir."},{"question":"PROCEPT hisselerinin riskleri nelerdir?","answer":"Mali s\u00fcrd\u00fcr\u00fclebilirlik riski, piyasa volatilitesi, reg\u00fclasyon ve geri \u00f6deme zorluklar\u0131, rekabet ortam\u0131 ve uygulama riskleri ba\u015fl\u0131ca risk fakt\u00f6rleridir."},{"question":"PROCEPT'in b\u00fcy\u00fcme kataliz\u00f6rleri nelerdir?","answer":"H\u0131zl\u0131 gelir b\u00fcy\u00fcmesi, b\u00fcy\u00fcyen kurulu sistem taban\u0131, marj iyile\u015ftirmeleri, uluslararas\u0131 pazar geni\u015flemesi ve prostat kanseri tedavisine y\u00f6nelik inovasyonlar \u00f6nemli kataliz\u00f6rlerdir."},{"question":"Yeni ba\u015flayanlar PROCEPT hisselerine yat\u0131r\u0131m yaparken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131p zamanla pozisyon art\u0131rmak, dolar maliyet ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak, uzun vadeli d\u00fc\u015f\u00fcnmek ve duygusal kararlar almaktan ka\u00e7\u0131nmak \u00f6nemlidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"PROCEPT BioRobotics Corporation (PRCT) hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"PRCT\" sembol\u00fc ile hisseyi aray\u0131n, mevcut fiyat\u0131 kontrol edin, uygun sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in, pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc belirleyin ve sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin."},{"question":"PROCEPT hisseleri i\u00e7in 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistlerin ortalama tahmini 67,94 $ olup, beklentilerin \u00fczerinde bir performans durumunda 80,60 $'a kadar \u00e7\u0131kabilir."},{"question":"PROCEPT hisselerinin riskleri nelerdir?","answer":"Mali s\u00fcrd\u00fcr\u00fclebilirlik riski, piyasa volatilitesi, reg\u00fclasyon ve geri \u00f6deme zorluklar\u0131, rekabet ortam\u0131 ve uygulama riskleri ba\u015fl\u0131ca risk fakt\u00f6rleridir."},{"question":"PROCEPT'in b\u00fcy\u00fcme kataliz\u00f6rleri nelerdir?","answer":"H\u0131zl\u0131 gelir b\u00fcy\u00fcmesi, b\u00fcy\u00fcyen kurulu sistem taban\u0131, marj iyile\u015ftirmeleri, uluslararas\u0131 pazar geni\u015flemesi ve prostat kanseri tedavisine y\u00f6nelik inovasyonlar \u00f6nemli kataliz\u00f6rlerdir."},{"question":"Yeni ba\u015flayanlar PROCEPT hisselerine yat\u0131r\u0131m yaparken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131p zamanla pozisyon art\u0131rmak, dolar maliyet ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak, uzun vadeli d\u00fc\u015f\u00fcnmek ve duygusal kararlar almaktan ka\u00e7\u0131nmak \u00f6nemlidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T17:27:28+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T17:27:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\",\"name\":\"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-25T17:27:28+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T17:27:28+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T17:27:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/","name":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r - PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-25T17:27:28+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"PROCEPT BioRobotics Corporation (PRCT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; PROCEPT BioRobotics Corporation (PRCT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":349478,"slug":"how-to-buy-procept-biorobotics-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu PROCEPT BioRobotics Corporation (PRCT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu PROCEPT BioRobotics Corporation (PRCT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/"},"pt_AA":{"locale":"pt_AA","id":349479,"slug":"how-to-buy-procept-biorobotics-corporation","post_title":"Como comprar a\u00e7\u00f5es da PROCEPT BioRobotics Corporation (PRCT) - Investimento em a\u00e7\u00f5es da PROCEPT BioRobotics Corporation (PRCT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-procept-biorobotics-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/349480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=349480"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/349480\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=349480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=349480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=349480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}